GGrantIndex
← Leaderboards

Moshe Arditi

Cedars-Sinai Medical Center

$23,213,171
Attributed
$25,614,569
Total exposure
19
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,614,569 · 19

By mechanism

R01$20,556,356 · 8
R21$2,348,500 · 5
R56$1,275,000 · 3
T32$1,132,659 · 1
R03$167,000 · 1
R29$135,054 · 1

Top collaborators

Most similar at Cedars-Sinai Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionInflammationCellsInflammatoryImmunePlayPathogenesisMediatingMouse ModelReceptorChronicCytokineIn VivoAtherosclerosisAffectMolecularBaseLeadPreventLesionVasculitisPathologyProductionCoronary Artery

Grant awards (72)

Role of Sex in Immune Stromal cell Interactions driving cardiovascular lesions in Kawasaki Disease vasculitis$582,830
R01 · FY2025 · HL · contact PI
Role of HMGB1 in an experimental model of Bacterial ligand induced Vasculitis$459,250
R21 · FY2025 · AI · contact PI
Role of Sex in Immune Stromal cell Interactions driving cardiovascular lesions in Kawasaki Disease vasculitis$582,830
R01 · FY2024 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2024 · AI · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2023 · AI · contact PI
RNA-Mediated Inter-Organelle Communication in Atherosclerosis$498,851
R01 · FY2023 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$191,748
R01 · FY2023 · AI · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2022 · AI · contact PI
RNA-Mediated Inter-Organelle Communication in Atherosclerosis$498,851
R01 · FY2022 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$99,079
R01 · FY2022 · AI · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2021 · AI · contact PI
RNA-Mediated Inter-Organelle Communication in Atherosclerosis$498,851
R01 · FY2021 · HL · contact PI
Role of neutrophils and eosinophils in bacterial ligand-induced vasculitis$582,362
R01 · FY2020 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$437,500
R01 · FY2020 · AI · contact PI
Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditis$437,500
R01 · FY2020 · AI · contact PI
Interaction with Rip2 and IL-17 in Chronic Lung Infection$321,840
R01 · FY2020 · AI · contact PI
Role of ER and Mitochondrial Stress in Coronary Arteritis and Vasculitis$255,000
R21 · FY2020 · AI · contact PI
Biological role of SARS-CoV2 Superantigenic structure in hyperinflammatory syndromes$184,894
R01 · FY2020 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$437,500
R01 · FY2019 · AI · contact PI
Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditis$437,500
R01 · FY2019 · AI · contact PI
Role of ER and Mitochondrial Stress in Coronary Arteritis and Vasculitis$212,500
R21 · FY2019 · AI · contact PI
Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditis$485,006
R01 · FY2018 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$437,500
R01 · FY2018 · AI · contact PI
Innate Immunity and Gender Differences in Melanoma$262,500
R21 · FY2018 · AI · contact PI
Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditis$551,250
R01 · FY2017 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$437,500
R01 · FY2017 · AI · contact PI
Atherosclerosis in SLE - OGG-1 as a novel target for therapeutic intervention$262,500
R21 · FY2017 · AI · contact PI
Innate Immunity and Gender Differences in Melanoma$218,750
R21 · FY2017 · AI · contact PI
Role of IL-1 in Bacterial ligand-induced vasculitis and myocarditis$437,500
R01 · FY2016 · AI · contact PI
Atherosclerosis in SLE - OGG-1 as a novel target for therapeutic intervention$218,750
R21 · FY2016 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$218,750
R01 · FY2016 · AI · contact PI
The Cedars-Sinai Immunobiology Training Program$187,097
T32 · FY2016 · AI · contact PI
Interaction with Rip2 and Th17 in Chronic Inflammation$437,500
R56 · FY2015 · AI · contact PI
Mitochondrial DNA Damage and Inflammasome Activation in Vascular Inflammation$250,500
R21 · FY2015 · AI · contact PI
Host Immune Responses to Chlamydia Pneumonaie Infection$425,000
R56 · FY2014 · AI · contact PI
Mitochondrial DNA Damage and Inflammasome Activation in Vascular Inflammation$208,750
R21 · FY2014 · AI · contact PI
The Cedars-Sinai Immunobiology Training Program$185,931
T32 · FY2014 · AI · contact PI
Innate Immune Mechanism in Chlamydia Induced Acceleration of Atherosclerosis$382,883
R01 · FY2013 · HL · contact PI
The Cedars-Sinai Immunobiology Training Program$185,043
T32 · FY2013 · AI · contact PI
Potential Role of IL-1B Therapies for Treatment of Vasculitis of Kawasaki Disease$83,500
R03 · FY2013 · AI · contact PI
Innate Immunity and Host Responses in Pathogenesis of Chlamydia Pneumoniae$412,500
R56 · FY2012 · AI · contact PI
Innate Immune Mechanism in Chlamydia Induced Acceleration of Atherosclerosis$402,188
R01 · FY2012 · HL · contact PI
Innate Immune Mechanisms and TLRs in Bacterial Ligand-Induced Arteritis$398,166
R01 · FY2012 · AI · contact PI
The Cedars-Sinai Immunobiology Training Program$192,527
T32 · FY2012 · AI · contact PI
Potential Role of IL-1B Therapies for Treatment of Vasculitis of Kawasaki Disease$83,500
R03 · FY2012 · AI · contact PI
Innate Immune Mechanisms in Chlamydia Pneumoniae Induced Acceleration of Atherosc$406,250
R01 · FY2011 · HL · contact PI
Innate Immune Mechanisms and TLRs in Bacterial Ligand-Induced Arteritis$398,166
R01 · FY2011 · AI · contact PI
The Cedars-Sinai Immunobiology Training Program$192,527
T32 · FY2011 · AI · contact PI
Innate Immune Mechanisms in Chlamydia Pneumoniae Induced Acceleration of Atherosc$406,250
R01 · FY2010 · HL · contact PI
Innate Immune Mechanisms and TLRs in Bacterial Ligand-Induced Arteritis$402,188
R01 · FY2010 · AI · contact PI
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection$367,781
R01 · FY2010 · AI · contact PI
The Cedars-Sinai Immunobiology Training Program$189,534
T32 · FY2010 · AI · contact PI
Innate Immune Mechanisms and TLRs in Bacterial Ligand-Induced Arteritis$406,250
R01 · FY2009 · AI · contact PI
Innate Immune Mechanisms in Chlamydia Pneumoniae Induced Acceleration of Atherosc$406,250
R01 · FY2009 · HL · contact PI
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection$371,495
R01 · FY2009 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$369,445
R01 · FY2009 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$452,912
R01 · FY2008 · AI · contact PI
Innate Immune Mechanisms and TLRs in Bacterial Ligand-Induced Arteritis$406,250
R01 · FY2008 · AI · contact PI
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection$401,495
R01 · FY2008 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$425,845
R01 · FY2007 · AI · contact PI
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection$378,690
R01 · FY2007 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$397,211
R01 · FY2006 · AI · contact PI
Role of Innate Immunity in Pathogenesis of Chlamydia Pneumonia Infection$390,000
R01 · FY2006 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$9,101
R01 · FY2006 · AI · contact PI
MD2 signaling in LPS/TLR4 induced cellular responses$351,000
R01 · FY2005 · AI
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESI$382,500
R01 · FY2004 · HL
MD2 signaling in LPS/TLR4 induced cellular responses$351,000
R01 · FY2004 · AI
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESI$382,500
R01 · FY2003 · HL
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESI$382,500
R01 · FY2002 · HL
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESI$75,000
R01 · FY2002 · HL
MOLECULAR PATHOGENESIS OF CHLAMYDIA-INDUCED ATHEROGENESI$363,950
R01 · FY2001 · HL
LPS INTERACTIONS WITH BRAIN ENDOTHELIAL CELLS$135,054
R29 · FY2000 · AI